Rachidi et al. (Rachidi et al., 2017) revealed that platelets can limit T cell-mediated anti-tumor immunity through the glycoprotein A repetitions predominant (GARP)-TGF-β axis. This evidence concerns the gene TGFB1 and neoplasm.